ACLY and colorectal carcinoma: EGCG significantly increases the phosphorylation of AMPKα (Thr172) to inhibit the expression of FASN, ACLY, ACC, and the transcriptional factor sterol regulating element-binding protein 1c (SREBP1c), resulting in de novo synthesis inhibition and reduced cell viability in CRC cells (Wang et al., 2021).